Medistim ASA (MEDI.OL)
NOK 161.0
(1.58%)
NOK 161.0
(1.58%)
| Year | Eps | Eps Growth |
|---|---|---|
| 2023 | 5.68 NOK | -9.12% |
| 2022 | 6.25 NOK | 25.25% |
| 2021 | 4.99 NOK | 30.97% |
| 2020 | 3.81 NOK | -1.55% |
| 2019 | 3.87 NOK | 23.25% |
| 2018 | 3.14 NOK | 19.85% |
| 2017 | 2.62 NOK | 21.86% |
| 2016 | 2.15 NOK | -3.59% |
| 2015 | 2.23 NOK | 28.9% |
| 2014 | 1.73 NOK | 17.69% |
| 2013 | 1.47 NOK | -11.45% |
| 2012 | 1.66 NOK | 95.29% |
| 2011 | 0.85 NOK | -16.67% |
| 2010 | 1.02 NOK | -32.45% |
| 2009 | 1.51 NOK | 98.68% |
| 2008 | 0.76 NOK | -49.67% |
| 2007 | 1.51 NOK | 58.95% |
| 2006 | 0.95 NOK | 50.79% |
| 2005 | 0.63 NOK | 34.04% |
| 2004 | 0.47 NOK | 0.0% |
| Year | Eps | Eps Growth |
|---|---|---|
| 2024 Q2 | 1.90 NOK | 42.86% |
| 2024 Q3 | 1.28 NOK | -32.63% |
| 2024 Q1 | 1.33 NOK | 26.67% |
| 2023 FY | - NOK | -9.12% |
| 2023 Q3 | 1.43 NOK | -20.56% |
| 2023 Q4 | 1.05 NOK | -26.57% |
| 2023 Q1 | 1.41 NOK | -20.79% |
| 2023 Q2 | 1.80 NOK | 27.66% |
| 2022 Q1 | 1.30 NOK | 47.73% |
| 2022 Q3 | 1.35 NOK | -25.82% |
| 2022 Q4 | 1.78 NOK | 31.85% |
| 2022 FY | - NOK | 25.25% |
| 2022 Q2 | 1.82 NOK | 40.0% |
| 2021 Q4 | 0.88 NOK | -14.56% |
| 2021 FY | - NOK | 30.97% |
| 2021 Q2 | 1.88 NOK | 56.67% |
| 2021 Q1 | 1.20 NOK | 60.0% |
| 2021 Q3 | 1.03 NOK | -45.21% |
| 2020 FY | - NOK | -1.55% |
| 2020 Q1 | 1.16 NOK | 36.47% |
| 2020 Q2 | 1.11 NOK | -4.31% |
| 2020 Q3 | 0.79 NOK | -28.83% |
| 2020 Q4 | 0.75 NOK | -5.06% |
| 2019 Q1 | 0.88 NOK | -32.82% |
| 2019 Q2 | 1.22 NOK | 38.64% |
| 2019 FY | - NOK | 23.25% |
| 2019 Q4 | 0.85 NOK | -7.61% |
| 2019 Q3 | 0.92 NOK | -24.59% |
| 2018 Q4 | 1.31 NOK | 114.75% |
| 2018 Q2 | 0.70 NOK | 34.62% |
| 2018 Q1 | 0.52 NOK | -24.64% |
| 2018 FY | - NOK | 19.85% |
| 2018 Q3 | 0.61 NOK | -12.86% |
| 2017 Q4 | 0.69 NOK | -6.76% |
| 2017 Q2 | 0.54 NOK | -16.92% |
| 2017 FY | - NOK | 21.86% |
| 2017 Q3 | 0.74 NOK | 37.04% |
| 2017 Q1 | 0.65 NOK | 103.13% |
| 2016 Q1 | 0.52 NOK | -22.39% |
| 2016 FY | - NOK | -3.59% |
| 2016 Q4 | 0.32 NOK | -48.39% |
| 2016 Q3 | 0.62 NOK | -10.14% |
| 2016 Q2 | 0.69 NOK | 32.69% |
| 2015 Q1 | 0.41 NOK | -32.79% |
| 2015 FY | - NOK | 28.9% |
| 2015 Q4 | 0.67 NOK | 17.54% |
| 2015 Q3 | 0.57 NOK | -1.72% |
| 2015 Q2 | 0.58 NOK | 41.46% |
| 2014 FY | - NOK | 17.69% |
| 2014 Q4 | 0.61 NOK | 41.86% |
| 2014 Q3 | 0.43 NOK | 7.5% |
| 2014 Q2 | 0.40 NOK | 37.93% |
| 2014 Q1 | 0.29 NOK | -32.56% |
| 2013 Q4 | 0.43 NOK | 79.17% |
| 2013 Q3 | 0.24 NOK | -50.0% |
| 2013 FY | - NOK | -11.45% |
| 2013 Q2 | 0.48 NOK | 50.0% |
| 2013 Q1 | 0.32 NOK | 261.17% |
| 2012 Q2 | 0.37 NOK | 8.82% |
| 2012 Q3 | 0.85 NOK | 129.73% |
| 2012 Q4 | 0.09 NOK | -89.58% |
| 2012 FY | - NOK | 95.29% |
| 2012 Q1 | 0.34 NOK | 183.33% |
| 2011 Q4 | 0.12 NOK | -33.33% |
| 2011 FY | - NOK | -16.67% |
| 2011 Q2 | 0.32 NOK | 39.13% |
| 2011 Q3 | 0.18 NOK | -43.75% |
| 2011 Q1 | 0.23 NOK | -32.35% |
| 2010 FY | - NOK | -32.45% |
| 2010 Q4 | 0.34 NOK | 30.77% |
| 2010 Q3 | 0.26 NOK | -13.33% |
| 2010 Q2 | 0.30 NOK | 130.77% |
| 2010 Q1 | 0.13 NOK | -38.1% |
| 2009 Q2 | 0.47 NOK | 2.17% |
| 2009 Q1 | 0.46 NOK | 0.0% |
| 2009 FY | - NOK | 98.68% |
| 2009 Q4 | 0.21 NOK | -40.0% |
| 2009 Q3 | 0.35 NOK | -25.53% |
| 2008 FY | - NOK | -49.67% |
| 2007 FY | - NOK | 58.95% |
| 2006 FY | - NOK | 50.79% |
| 2005 FY | - NOK | 34.04% |
| 2004 FY | - NOK | 0.0% |
| Name | Eps | Eps Difference |
|---|---|---|
| Gentian Diagnostics ASA | -0.69 NOK | 923.188% |
| Lifecare AS | -0.29 NOK | 2058.621% |